← Leaderboards
Ahmet Hoke
Johns Hopkins University
$10,977,966
Attributed
$12,781,688
Total exposure
14
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,781,688 · 14
By mechanism
R01$7,809,483 · 4
P30$3,288,696 · 4
R56$539,360 · 1
R24$492,000 · 1
R21$450,313 · 1
S10$171,836 · 1
Top collaborators
- Kannan Rangaramanujam4 shared
- Barbara Stauch Slusher4 shared
- Gerald Warren Hart1 shared
- Mehboob A Hussain1 shared
- Anne M Murphy1 shared
- Quan Dong Nguyen1 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Richard Anthony Edward Edden$15,962,994
- Barbara Stauch Slusher$18,499,514
- Peter B Barker$12,208,416
- Kannan Rangaramanujam$10,355,612
- Takashi Tsukamoto$11,312,957
Others in their field
Top investigators on “Grant”
- David R. Weir · University Of Michigan At Ann Arbor$373,949,788
- David Heimbrook · Leidos Biomedical Research, Inc.$341,196,902
- Eric S Lander · Whitehead Institute For Biomedical Res$323,181,457
- Jeffrey P Krischer · University Of South Florida$258,583,867
- Lawrence Corey · Fred Hutchinson Cancer Center$253,286,867
- Barton F Haynes · Duke University$243,251,908
Research focus
GrantResearch PersonnelProgramsAffectMolecularDesignNeurologicNovel TherapeuticsCellsPharmaceutical PreparationsLeadCollaborationsClinical ResearchFundingEffective TherapyPlayHigh RiskPathway InteractionsInnovationMentorsPilot ProjectsDistalLinkUnited States National Institutes Of Health
Grant awards (43)
Macrophage-targeted dendrimer 2-PMPA for the treatment of age-related sarcopenia$540,506
R01 · FY2025 · AG
JHU Center for the Advancement of HIV Neurotherapeutics (JHU CAHN) - Development Core$248,248
P30 · FY2025 · MH · contact PI
Macrophage-targeted dendrimer 2-PMPA for the treatment of age-related sarcopenia$580,168
R01 · FY2024 · AG
MAP4K4 inhibition to prevent CIPN$450,313
R21 · FY2024 · NS · contact PI
JHU Center for the Advancement of HIV Neurotherapeutics (JHU CAHN) - Development Core$226,980
P30 · FY2024 · MH · contact PI
Macrophage-targeted dendrimer 2-PMPA for the treatment of age-related sarcopenia$518,067
R01 · FY2023 · AG
JHU Center for the Advancement of HIV Neurotherapeutics (JHU CAHN) - Development Core$248,248
P30 · FY2023 · MH · contact PI
Macrophage-targeted dendrimer 2-PMPA for the treatment of age-related sarcopenia$476,442
R01 · FY2022 · AG
JHU Center for the Advancement of HIV Neurotherapeutics (JHU CAHN) - Development Core$248,248
P30 · FY2022 · MH · contact PI
Mechanisms of neuroprotection in diabetic peripheral neuropathy$539,360
R56 · FY2021 · NS · contact PI
Development Core$231,423
P30 · FY2021 · MH · contact PI
Development Core$231,423
P30 · FY2020 · MH · contact PI
Mechanism of neuroprotection in chemotherapy induced peripheral neuropathy$354,375
R01 · FY2019 · NS · contact PI
Development Core$248,295
P30 · FY2019 · MH · contact PI
Mechanism of neuroprotection in chemotherapy induced peripheral neuropathy$354,375
R01 · FY2018 · NS · contact PI
Development Core$231,308
P30 · FY2018 · MH · contact PI
Mechanism of neuroprotection in chemotherapy induced peripheral neuropathy$354,375
R01 · FY2017 · NS · contact PI
Development Core$231,070
P30 · FY2017 · MH · contact PI
Mechanism of neuroprotection in chemotherapy induced peripheral neuropathy$354,375
R01 · FY2016 · NS · contact PI
Mechanism of neuroprotection in chemotherapy induced peripheral neuropathy$354,375
R01 · FY2015 · NS · contact PI
Developmental Core$215,130
P30 · FY2015 · MH · contact PI
Developmental Core$225,928
P30 · FY2014 · MH · contact PI
Developmental Core$213,649
P30 · FY2013 · MH · contact PI
Developmental Core$228,726
P30 · FY2012 · MH · contact PI
Developmental Core$17,988
P30 · FY2012 · MH · contact PI
The Foundation for Peripheral Neuropathy Research Symposium 2012$10,000
R13 · FY2012 · NS · contact PI
HIV and antiretroviral toxic neuropathy$401,800
R01 · FY2011 · NS · contact PI
Developmental Core$242,032
P30 · FY2011 · MH · contact PI
"Peripheral Nerve Society Biannual Meeting 2011"$20,000
R13 · FY2011 · NS · contact PI
Mechanisms of Glucose Toxicity$492,000
R24 · FY2010 · DK
HIV and antiretroviral toxic neuropathy$405,900
R01 · FY2010 · NS · contact PI
Seahorse XF-96 Analyzer for Non-Invasive Monitoring of Mitochondrial Function$171,836
S10 · FY2010 · RR · contact PI
HIV and antiretroviral toxic neuropathy$410,000
R01 · FY2009 · NS · contact PI
HIV and antiretroviral toxic neuropathy$147,600
R01 · FY2009 · NS · contact PI
HIV and antiretroviral toxic neuropathy$410,000
R01 · FY2008 · NS · contact PI
HIV and antiretroviral toxic neuropathy$410,000
R01 · FY2007 · NS · contact PI
Peripheral neurotoxicity by the HIV-1 coat protein gp120$250,951
R01 · FY2007 · NS · contact PI
Peripheral neurotoxicity by the HIV-1 coat protein gp120$258,446
R01 · FY2006 · NS · contact PI
Peripheral neurotoxicity by the HIV-1 coat protein gp120$13,450
R01 · FY2006 · NS · contact PI
An in vitro Model of Antiretroviral Toxic Neuropathy$310,650
R01 · FY2005 · NS
An in vitro Model of Antiretroviral Toxic Neuropathy$310,650
R01 · FY2004 · NS
An in vitro Model of Antiretroviral Toxic Neuropathy$297,379
R01 · FY2003 · NS
An in vitro Model of Antiretroviral Toxic Neuropathy$295,599
R01 · FY2002 · NS